BridgeMD
New treatment option for Subacute Stroke
Official title Segmental Vibrator With NMES on Lower Limb Function in Subacute Stroke
ClinicalTrials.gov ID: NCT06927206
What this study is testing
- What it's testing
- Stroke is one of the world's leading causes of death and disability. It can cause a variety of motor disorders, such as apraxia, sensory deficits, abnormal muscle tone, inadequate weight transfer, lack of fine motor skills, incoordination, and balance deficit.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 60
You may be able to join if
- Both male and female patients were included in the study.
- The age range of participants was between 45 and 60 years.
- Participants that were diagnosed with ischemic stroke patient.
- Participants had experienced sub-acute ischemic stroke, specifically 15 days to 12 weeks post-stroke.
- Montreal Cognitive Assessment scores falling within the range of 18-24 were necessary.
You likely can't join if
- People who had a history of serious neurological or mental conditions that would have impeded lower limb motor recovery-aside from stroke-were not...
- Individuals with severe arthritis or joint injuries, among other illnesses that would have interfered with treatment or evaluations, were not allowed...
- Individuals who had significant hearing or vision impairments that would have hampered treatment or evaluations were not included.
- Individuals undergoing anti-spatial therapy or other clinical trials, those with bilateral brain lesions, and those with ischemic involvement of the...
- Participants having metal implants e. g cardiac pacemaker and skin lesion at the site of stimulation electrodes were excluded.
See the full eligibility criteria
- Both male and female patients were included in the study.
- The age range of participants was between 45 and 60 years.
- Participants that were diagnosed with ischemic stroke patient.
- Participants had experienced sub-acute ischemic stroke, specifically 15 days to 12 weeks post-stroke.
- Montreal Cognitive Assessment scores falling within the range of 18-24 were necessary.
- Modified Ashworth scale scores had to be less than +1
- National Institutes of Health Stroke Scale (NIHSS) score falling within the range of 1 to 15 were necessary.
- Participants feel no pain from the vibrator.
- It was anticipated that participants would either be able to give informed consent or have a legal representative who could do so.
- People who had a history of serious neurological or mental conditions that would have impeded lower limb motor recovery-aside from stroke-were not included.
- Individuals with severe arthritis or joint injuries, among other illnesses that would have interfered with treatment or evaluations, were not allowed to participate.
- Individuals who had significant hearing or vision impairments that would have hampered treatment or evaluations were not included.
- Individuals undergoing anti-spatial therapy or other clinical trials, those with bilateral brain lesions, and those with ischemic involvement of the cerebellum or basal ganglia were not allowed to participate.
- Participants having metal implants e. g cardiac pacemaker and skin lesion at the site of stimulation electrodes were excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.